Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent

Journal of Leukocyte Biology

Volumn 80, Issue 1, 2006, Pages 133-144

  Fahey, Angela J ^a   Robins, R Adrian ^a   Kindle, Karin B ^a   Heery, David M ^a   Constantinescu, Cris S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Modulation; Signal transduction

Indexed keywords

BETA INTERFERON; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; MIFEPRISTONE; STAT4 PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-23; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

EID: 33751533959     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0605296     Document Type: Article

References (49)

1. Ashwell, J. D., Lu, F. W., Vacchio, M. S. (2000) Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18, 309-345.
2. Agarwal, S. K., Marshall Jr., G. D. (2001) Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J. Interferon Cytokine Res. 21, 147-155.
3. DeKruyff, R. H., Fang, Y., Umetsu, D. T. (1998) Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 160, 2231-2237.
4. Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y., Aringer, M., Frucht, D. M., Chrousos, G. P., O'Shea, J. J. (2000) Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol. 164, 1768-1774.
5. Trinchieri, G. (1998) Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83-243.
6. Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rude, E., Germann, T. (1994) T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24, 793-798.
7. Trinchieri, G., Pflanz, S., Kastelein, R. A. (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641-644.
8. Bacon, C. M., Petricoin III, E. F., Ortaldo, J. R., Rees, R. C., Larner, A. C., Johnston, J. A., O'Shea, J. J. (1995) Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7307-7311.
9. O'Shea, J. J., Visconti, R. (2000) Type 1 IFNs and regulation of TH1 responses: enigmas both resolved and emerge. Nat. Immunol. 1, 17-19.
10. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725.
11. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708.
12. Karp, C. L., Biron, C. A., Irani, D. N. (2000) Interferon β in multiple sclerosis: is IL-12 suppression the key? Immunol. Today 21, 24-28.
13. Rep, M. H., Schrijver, H. M., van Lopik, T., Hintzen, R. Q., Roos, M. T., Ader, H. J., Polman, C. H., van Lier, R. A. (1999) Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients. J. Neuroimmunol. 96, 92-100.
14. Mosmann, T. R., Moore, K. W. (1991) The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12, A49-A53.
15. Howard, M., O'Garra, A. (1992) Biological properties of interleukin 10. Immunol. Today 13, 198-200.
16. Ramirez, F., Fowell, D. J., Puklavec, M., Simmonds, S., Mason, D. (1996) Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156, 2406-2412.
17. Uzel, G., Frucht, D. M., Fleisher, T. A., Holland, S. M. (2001) Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin. Immunol. 100, 270-276.
18. Strausberg, R. L., Feingold, E. A., Grouse, L. H., Derge, J. G., Klausner, R. D., Collins, F. S., Wagner, L., Shenmen, C. M., Schuler, G. D., Altschul, S. F., et al. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99, 16899-16903.
19. Applied Biosystems. (1997) User Bulletin #2: ABI PRISM 7700 Sequence Detection System. Foster City, CA, Applied Biosystems.
20. Kaminuma, O., Kitamura, F., Kitamura, N., Miyagishi, M., Taira, K., Yamamoto, K., Miura, O., Miyatake, S. (2004) GATA-3 suppresses IFN-γ promoter activity independently of binding to cis-regulatory elements. FEBS Lett. 570, 63-68.
21. Ma, W., Lim, W., Gee, K., Aucoin, S., Nandan, D., Kozlowski, M., Diaz-Mitoma, F., Kumar, A. (2001) The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276, 13664-13674.
22. Nguyen, K. B., Watford, W. T., Salomon, R., Hofmann, S. R., Pien, G. C., Morinobu, A., Gadina, M., O'Shea, J. J., Biron, C. A. (2002) Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection. Science 297, 2063-2066.
23. Nakahira, M., Ahn, H. J., Park, W. R., Gao, P., Tomura, M., Park, C. S., Hamaoka, T., Ohta, T., Kurimoto, M., Fujiwara, H. (2002) Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol. 168, 1146-1153.
24. Mosmann, T. R., Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
25. Furlan, R., Bergami, A., Lang, R., Brambilla, E., Franciotta, D., Martinelli, V., Comi, G., Panina, P., Martino, G. (2000) Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4. J. Neuroimmunol. 111, 86-92.
26. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
27. Biron, C. A. (2001) Interferons α and β as immune regulators - a new look. Immunity 14, 661-664.
28. Adorini, L. (2003) Cytokine-based immunointervention in the treatment of autoimmune diseases. Clin. Exp. Immunol. 132, 185-192.
29. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
30. Wandinger, K. P., Sturzebecher, C. S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L. M., McFarland, H. F., Martin, R. (2001) Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 50, 349-357.
31. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., Weinshenker, B. G. (2000) Multiple sclerosis. N. Engl. J. Med. 343, 938-952.
32. Rogge, L., D'Ambrosio, D., Biffi, M., Penna, G., Minetti, L. J., Presky, D. H., Adorini, L., Sinigaglia, F. (1998) The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 161, 6567-6574.
33. Brinkmann, V., Geiger, T., Alkan, S., Heusser, C. H. (1993) Interferon α increases the frequency of interferon γ-producing human CD4+ T cells. J. Exp. Med. 178, 1655-1663.
34. Sega, S., Wraber, B., Mesec, A., Horvat, A., Ihan, A. (2004) IFN-β1a and IFN-β1b have different patterns of influence on cytokines. Clin. Neurol. Neurosurg. 106, 255-258.
35. McRae, B. L., Semnani, R. T., Hayes, M. P., van Seventer, G. A. (1998) Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160, 4298-4304.
36. Kaplan, M. H., Sun, Y. L., Hoey, T., Grusby, M. J. (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
37. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A., Doherty, P. C., Grosveld, G. C., et al. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
38. Athie-Morales, V., Smits, H. H., Cantrell, D. A., Hilkens, C. M. (2004) Sustained IL-12 signaling is required for Th1 development. J. Immunol. 172, 61-69.
39. Pfeffer, L. M., Constantinescu, S. (1997) Interferon Therapy in Multiple Sclerosis. New York, NY, Marcel Dekker.
40. Platanias, L. C., Uddin, S., Colamonici, O. R. (1994) Tyrosine phosphorylation of the α and β subunits of the type I interferon receptor. Interferon-β selectively induces tyrosine phosphorylation of an α subunit-associated protein. J. Biol. Chem. 269, 17761-17764.
41. John, J., McKendry, R., Pellegrini, S., Flavell, D., Kerr, I. M., Stark, G. R. (1991) Isolation and characterization of a new mutant human cell line unresponsive to α and β interferons. Mol. Cell. Biol. 11, 4189-4195.
42. Barbulescu, K., Becker, C., Meyer zum Buschenfelde, K. H., Neurath, M. F. (1998) Regulation of protein-DNA interactions at the interferon-γ gene promoter by corticosteroids. Implications for inflammatory bowel diseases. Ann. N. Y. Acad. Sci. 859, 194-197.
43. Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M. J., Young, H. A. (1995) Negative transcriptional regulation of the interferon-γ promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 270, 12548-12556.
44. Vanden Eijnden, S., Goriely, S., De Wit, D., Willems, F., Goldman, M. (2005) IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur. J. Immunol. 35, 469-475.
45. Gasperini, C., Pozzilli, C., Bastianello, S., Koudriavtseva, T., Galgani, S., Millefiorini, E., Paolillo, A., Horsfield, M. A., Bozzao, L., Fieschi, C. (1998) Effect of steroids on Gd-enhancing lesions before and during recombinant β interferon 1a treatment in relapsing remitting multiple sclerosis. Neurology 50, 403-406.
46. Uitdehaag, B. M., Hoekstra, K., Koper, J. W., Polman, C. H., Dijkstra, C. D. (2001) IFN-7beta;1b augments glucocorticoid-induced suppression of tumor necrosis factor-α production by increasing the number of glucocorticoid receptors on a human monocytic cell line. J. Interferon Cytokine Res. 21, 133-135.
47. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K., Adorini, L. (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181, 817-821.
48. Constantinescu, C. S., Wysocka, M., Hilliard, B., Ventura, E. S., Lavi, E., Trinchieri, G., Rostami, A. (1998) Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161, 5097-5104.
49. Bright, J. J., Musuro, B. F., Du, C., Sriram, S. (1998) Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol. 82, 22-30.